Search Stock News and Analysis

Options Traders Blitz Biotech ETFs as Trump Talks Drug Prices

https://www.schaeffersresearch.com/content/options/2018/05/11/options-traders-blitz-biotech-etfs-as-trump-talks-drug-prices

5/11/2018 2:32 PM

Healthcare stocks are in focus this afternoon, after President Donald Trump unveiled a plan lower drug prices not long ago, entitled "American Patients First." The sector is trading higher following t...

Time to Buy These 2 Pharma Stocks

https://www.schaeffersresearch.com/content/analysis/2018/04/11/time-to-buy-these-2-pharma-stocks

4/11/2018 2:03 PM

Biotechs struggled in the latter half of March, with the iShares Nasdaq Biotechnology ETF (IBB) shedding more than 13% from its mid-March high of $115.60 to its early April lows just north of $100. Th...

Buy Calls On These 2 Biotech Stocks

https://www.schaeffersresearch.com/content/analysis/2018/03/13/buy-calls-on-these-2-biotech-stocks

3/13/2018 3:03 PM

Pharmaceutical stocks went on a tear recently, with the iShares Nasdaq Biotechnology ETF (IBB) fresh off a seven-day winning streak -- its longest series of consecutive gains since March 2015. While...

Put Options Hot as IBB Tests Technical Support

https://www.schaeffersresearch.com/content/analysis/2017/12/08/put-options-hot-as-ibb-tests-technical-support

12/8/2017 2:38 PM

It's a big day for biotechs, with Denali Therapeutics (DNLI) debuting on the Nasdaq above its initial public offering price (IPO), and Sage Therapeutics (SAGE) continuing to hit record highs. Amid th...

When Biotech Strength Becomes an S&P Buy Signal

https://www.schaeffersresearch.com/content/bgs/2017/09/18/when-biotech-strength-becomes-an-s-p-buy-signal

9/18/2017 2:46 PM

The biotech sector has generated some keen interest lately, driven in no small part by the recent FDA approval of the first CAR T-cell therapy for cancer treatment. This development has been the focus...

PEOPLE ALSO SEARCH FOR